The global hepatocellular carcinoma treatment market is expected to grow at a CAGR of 17.39% during 2022-2027
MARKET OUTLOOK. Hepatocellular carcinoma (HCC) is the most common form of liver cancer and accounts for ~90% of cases.
Read more at Yahoo Finance
